Panel Discussion: Data Access in Practice: Building Sustainable, Ethical, & Scalable RWE Across Europe

11:40 am - Wednesday 25th February 2026

  • How can pharma, registries, and vendors collaborate to avoid duplication and improve efficiency in finding usable datasets?
  • What frameworks are needed to establish fair and transparent remuneration for physicians, patients, and database owners?
  • How do we balance sustainability of smaller registries with industry’s need for scale and interoperability?
  • How should pharma assess the risks of supporting new registries, and what funding and contracting models best incentivise long-term patient recruitment?
  • Where can AI and automation play a role in reducing healthcare system burden and improving data timeliness?

Speakers:

RWE Lead
Eli Lilly & Co.
Senior Director, Market Access, Pricing, Health Economics & Outcomes Research
Immunome, Inc.
Real World Data & Healthcare Technology Manager
Amgen Inc.
Real World Evidence Manager
AstraZeneca